Search research articles
Contact Us
Filters
Showing results (241-250 of 299) with videos related to
Page
of 30
Sort By:
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Gynecologic Oncology
|
September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
E J Shpall, D Clarke-Pearson, J T Soper, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
J M Niloff, R C Knapp, P T Lavin, et al.
Experimental Cell Research
|
August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells
Y J Lidor, F J Xu, O Martínez-Maza, et al.
Cancer Research
|
October 1, 1988
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function
P R Conkling, C C Chua, P Nadler, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support
W A Franklin, E J Shpall, P Archer, et al.
Bone Marrow Transplantation
|
February 1, 1991
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation
E J Shpall, R C Bast, W T Joines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 1991
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial
E J Shpall, R B Jones, R C Bast, et al.
Human Molecular Genetics
|
April 1, 1994
A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1
I G Campbell, H M Nicolai, W D Foulkes, et al.
Cancer Research
|
March 1, 1983
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum
R C Bast, J S Berek, R Obrist, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 299) with videos related to
Sort By:
Page
of 30
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Gynecologic Oncology
|
September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer
E J Shpall, D Clarke-Pearson, J T Soper, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1986
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
J M Niloff, R C Knapp, P T Lavin, et al.
Experimental Cell Research
|
August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells
Y J Lidor, F J Xu, O Martínez-Maza, et al.
Cancer Research
|
October 1, 1988
Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function
P R Conkling, C C Chua, P Nadler, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support
W A Franklin, E J Shpall, P Archer, et al.
Bone Marrow Transplantation
|
February 1, 1991
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation
E J Shpall, R C Bast, W T Joines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 1991
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial
E J Shpall, R B Jones, R C Bast, et al.
Human Molecular Genetics
|
April 1, 1994
A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1
I G Campbell, H M Nicolai, W D Foulkes, et al.
Cancer Research
|
March 1, 1983
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum
R C Bast, J S Berek, R Obrist, et al.
Page
of 30